FI51353B - - Google Patents

Info

Publication number
FI51353B
FI51353B FI3193/69A FI319369A FI51353B FI 51353 B FI51353 B FI 51353B FI 3193/69 A FI3193/69 A FI 3193/69A FI 319369 A FI319369 A FI 319369A FI 51353 B FI51353 B FI 51353B
Authority
FI
Finland
Application number
FI3193/69A
Other languages
Finnish (fi)
Other versions
FI51353C (fi
Inventor
Kalman Harsanyi
Karoly Nador
Kalman Takacs
Dezso Korbonits
Pal Kiss
Antal Simay
Istvan Bodrogi
Laszlo Tardos
Gyoergy Leszkovszky
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of FI51353B publication Critical patent/FI51353B/fi
Application granted granted Critical
Publication of FI51353C publication Critical patent/FI51353C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D283/00—Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups C07D275/00 - C07D281/00
    • C07D283/02—Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups C07D275/00 - C07D281/00 having the hetero atoms in positions 1 and 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI693193A 1968-11-06 1969-11-05 Menetelmä terapeuttisesti käytettävän 2-(naftyyli-1-amino)-4H-5,6-dihy dro-1,3-tiatsiinin valmistamiseksi. FI51353C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUCI000832 1968-11-06

Publications (2)

Publication Number Publication Date
FI51353B true FI51353B (es) 1976-08-31
FI51353C FI51353C (fi) 1976-12-10

Family

ID=10994356

Family Applications (1)

Application Number Title Priority Date Filing Date
FI693193A FI51353C (fi) 1968-11-06 1969-11-05 Menetelmä terapeuttisesti käytettävän 2-(naftyyli-1-amino)-4H-5,6-dihy dro-1,3-tiatsiinin valmistamiseksi.

Country Status (16)

Country Link
US (1) US3775409A (es)
AR (2) AR197371A1 (es)
AT (3) AT295524B (es)
BR (1) BR6913940D0 (es)
CA (1) CA960217A (es)
CH (1) CH537409A (es)
DE (1) DE1954584A1 (es)
FI (1) FI51353C (es)
FR (1) FR2024805B1 (es)
GB (1) GB1286315A (es)
IL (1) IL33292A (es)
NL (1) NL6916638A (es)
NO (1) NO129464B (es)
PL (1) PL80326B1 (es)
SE (2) SE7414477L (es)
SU (1) SU465792A3 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2015675A1 (de) * 1970-04-02 1971-10-21 Farbenfabriken Bayer Ag, 5090 Lever Kusen Ektoparasitizide Mittel
US4054652A (en) * 1976-06-15 1977-10-18 Merck & Co., Inc. Dihydro- and tetrahydro- iminothiazines
HU191408B (en) * 1984-04-25 1987-02-27 Egis Gyogyszergyar,Hu Process for preparing new imino-thiazolidine derivatives
WO2004110978A2 (en) * 2003-06-10 2004-12-23 Smithkline Beecham Corporation 1-aminonaphthalenes as modulators of androgen, glucocorticoid, mineralocorticoid and progesterone receptors
CN103936690B (zh) 2005-10-25 2016-06-08 盐野义制药株式会社 氨基二氢噻嗪衍生物
EP2147914B1 (en) 2007-04-24 2014-06-04 Shionogi&Co., Ltd. Aminodihydrothiazine derivatives substituted with cyclic groups
JP5383483B2 (ja) 2007-04-24 2014-01-08 塩野義製薬株式会社 アルツハイマー症治療用医薬組成物
ES2738123T3 (es) 2008-06-13 2020-01-20 Shionogi & Co Derivado heterocíclico que contiene azufre que tiene actividad inhibitoria de ß-secretasa
JPWO2010047372A1 (ja) * 2008-10-22 2012-03-22 塩野義製薬株式会社 Ｂａｃｅ１阻害活性を有する２−アミノピリミジン−４−オンおよび２−アミノピリジン誘導体
BR112012013854A2 (pt) 2009-12-11 2019-09-24 Shionogi & Co derivados de oxazina.
JP5766198B2 (ja) 2010-10-29 2015-08-19 塩野義製薬株式会社 縮合アミノジヒドロピリミジン誘導体
US8927721B2 (en) 2010-10-29 2015-01-06 Shionogi & Co., Ltd. Naphthyridine derivative
US8883779B2 (en) 2011-04-26 2014-11-11 Shinogi & Co., Ltd. Oxazine derivatives and a pharmaceutical composition for inhibiting BACE1 containing them
WO2014065434A1 (en) 2012-10-24 2014-05-01 Shionogi & Co., Ltd. Dihydrooxazine or oxazepine derivatives having bace1 inhibitory activity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1356908A (fr) * 1959-12-17 1964-04-03 Dausse Lab Composés de la série des amino-2 thiazolines et leur préparation
DE1191821B (de) * 1962-07-05 1965-04-29 Bayer Ag Verfahren zur Herstellung von Derivaten des 2-Phenylamino-4 H-5, 6-dihydro-1, 3-thiazins

Also Published As

Publication number Publication date
BR6913940D0 (pt) 1973-02-27
IL33292A (en) 1973-04-30
CH537409A (de) 1973-05-31
IL33292A0 (en) 1970-01-29
AR192865A1 (es) 1973-03-21
CA960217A (en) 1974-12-31
SE7414477L (es) 1974-11-18
AT297698B (de) 1972-04-10
NO129464B (es) 1974-04-16
SU465792A3 (ru) 1975-03-30
GB1286315A (en) 1972-08-23
AT295524B (de) 1972-01-10
PL80326B1 (en) 1975-08-30
FI51353C (fi) 1976-12-10
DE1954584A1 (de) 1970-05-14
FR2024805A1 (es) 1970-09-04
US3775409A (en) 1973-11-27
FR2024805B1 (es) 1973-12-21
NL6916638A (es) 1970-05-11
SE7414478L (es) 1974-11-18
AT297699B (de) 1972-04-10
AR197371A1 (es) 1974-04-05

Similar Documents

Publication Publication Date Title
AU428130B2 (es)
AU2374870A (es)
FI51353B (es)
AU416157B2 (es)
AU2952567A (es)
AU2581067A (es)
AU4811568A (es)
AU421558B1 (es)
AU3789668A (es)
AU3224368A (es)
AU2580267A (es)
BE727410A (es)
BE726731A (es)
AU3083868A (es)
BE728403A (es)
BE728294A (es)
BE727983A (es)
BE727868A (es)
BE727654A (es)
BE728574A (es)
BE727060A (es)
BE726998A (es)
BE726989A (es)
BE709319A (es)
BE726760A (es)